The markets opened lower with the Dow slipping 10 points to 17,855 ahead of the Federal Reserve's policy meeting beginning tomorrow. Nasdaq lost 7 points to 4,886.
On the upside
LinkedIn (NYSE: LNKD) will be acquired by Microsoft (Nasdaq: MSFT) in an all-cash deal valued at approximately $26.2 billion.
Eleven Biotherapeutics (Nasdaq: EBIO) entered an exclusive license agreement for Roche to develop and commercialize EBI-031.
Shares of COPsync (Nasdaq: COYN) surged in the aftermath of Orlando's deadly mass shooting early Sunday morning.
On the downside
Marinus Pharmaceuticals (Nasdaq: MRNS) reported disappointing results from a Phase 3 study of ganaxolone to treat adults with drug-resistant focal onset seizures.
DA Davidson downgraded Emerge Energy Services (NYSE: EMES) from a Buy rating to an Underperform rating.
Insider Monkey noted that hedge funds increased their holdings in ArcelorMittal (NYSE: MT) in the first quarter but the stock price fell.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 4 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 slipped a point to 2,094. Bitcoin leaped $41 to $694.
